ISOLATION AND IN SILICO ANTIVIRAL POTENTIAL OF CARYOPHYLLENE AND EUCALYPTOL AGAINST SARS-COV-2 AS ANTI-COVID-19 DRUG CANDIDATE
Background and purpose: COVID-19 is a respiratory disease caused by infection of SARS-COV-2. Even though the COVID-19 vaccines are available, vaccinated individuals are still infected by the SARS-CoV-2. Additionally, the current therapy for COVID-19 uses nucleoside analog and protease inhibitor t...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/66234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Background and purpose: COVID-19 is a respiratory disease caused by infection
of SARS-COV-2. Even though the COVID-19 vaccines are available, vaccinated
individuals are still infected by the SARS-CoV-2. Additionally, the current therapy
for COVID-19 uses nucleoside analog and protease inhibitor that is generally used
in HIV treatment. However, as the use increases, these drugs provide serious side
effects. Therefore, discovering new anti-COVID-19 that is more effective with
minimum side effects needs to be undertaken. Caryophyllene and eucalyptol are
natural product compounds that have been studied and reported to provide broad
pharmacological activity. This research is an effort to isolate and evaluate the anti-
COVID-19 potential of caryophyllene and eucalyptol by understanding the
molecular interactions with various proteins that play a role in the SARS-CoV-2
infection cycle. Methods: Caryophyllene isolation was carried out using silver
nitrate-impregnated silica gel column chromatography with the n-hexane-ethyl
acetate (8:2) as the mobile phase. The isolation of eucalyptol was done using two
steps of intermittent column chromatography using n-hexane-ethyl acetate (8:2) as
the first mobile phase system and n-hexane-ethyl acetate (9.5:0.5) as the second
mobile phase system. The evaluation of the anti-COVID-19 potential of
caryophyllene and eucalyptol was implemented using a molecular docking study
against ACE-2, TMPRSS2, SARS-CoV-2 Mpro, SARS-CoV-2 Plpro, dan SARS-
CoV-2 macrodomain. The molecular docking study was done using Autodock 4.2,
assisted by Autodock Tools. The protein preparation and result visualization were
carried out using Biovia Discovery Studio. Results: Isolation of caryophyllene
using column chromatography with n-hexane-acetone (7:3) as the mobile phase
provides caryophyllene with a purity of 79%. Purification of caryophyllene using
silver nitrate-impregnated silica gel column chromatography can separate the
isomer (humulene and caryophyllene oxide) and gives caryophyllene a purity of
98%. On the other hand, the isolation of eucalyptol using two steps of intermittent
column chromatography provide eucalyptol with a purity of 94%. The molecular
docking study revealed that caryophyllene possesses an excellent affinity to SARS-
CoV-2 papain-like protease with a free binding energy and inhibition constant of -
7.22 kcal/mol and 5.07 µM, respectively. Meanwhile, eucalyptol has a poor affinity
for target proteins. Conclusion: Caryophyllene can be separated and purified from
its isomers using the silver nitrate-impregnated silica gel column chromatography
technique obtaining high purity of caryophyllene. The isolation of eucalyptol using
two steps of intermittent column chromatography provides high purity of
eucalyptol. Caryophyllene is potentially developed as SARS-CoV-2 papain-like
protease inhibitor according to the prediction of molecular interaction by
molecular docking study.
|
---|